8 Things Most Americans Dont Know About Retirement
DOL Issues Temporary Enforcement Policy on Fiduciary Rule
What HNWs Want That Advisors Aren’t Doing
The Trump rally has been good to Raymond James Financial and two other companies, which are set to join the S&P 500 index next Monday.
“Based on our review of the market’s progress – the S&P 500 is up 5.5% since the start of the year and 19% over the last 12 months – the Index Committee has revised the market cap guidelines for the S&P 500, S&P MidCap 400 and S&P SmallCap 600,” said David M. Blitzer, chairman of S&P’s Index Committee, in a statement.
Assets under administration ended the year at $585.6 billion, a jump of 24% from December 2015 and 2% from September 2016. Private Client Group assets in fee-based accounts stand at $240.2 billion, or 41% of total AUA, representing a 26% increase from last year and a 4% jump from the earlier quarter.
Best High Tech Stocks To Buy Right Now: Industrial Select Sector SPDR ETF (XLI)
- [By Ben Levisohn]
Shares of United Technologies have dropped 1% to $110.54 at 2:49 p.m. today, while the Industrial Select Sector SPDR ETF (XLI) has gained 1.1% to $64.39.
- [By Ben Levisohn]
Shares of General Electric have dipped 0.1% to $29.52 at 1:47 p.m. today, while the Industrial Select Sector SPDR ETF (XLI) has risen 0.5% to $66.70.
- [By Ben Levisohn]
Shares of Deere have ticked up 0.1% to $103.49 at 1:29 p.m. today, while Caterpillar has advanced 0.1% to $93.28. The Industrial Select Sector SPDR ETF (XLI) is up 0.1% at $62.50.
Best High Tech Stocks To Buy Right Now: ZELTIQ Aesthetics, Inc.(ZLTQ)
- [By James E. Brumley]
This week, Botox maker Allergan plc (NYSE:AGN) shelled out $2.5 billion for body-sculpting outfit Zeltiq Aesthetics Inc (NASDAQ:ZLTQ). The pairing is a nice opportunity for both organizations to cross-sell to one another’s customers. Allergan’s Botox customers seeking a more youthful face will also likely want the better body Zeltiq Aesthetics provides, and Zeltiq Aesthetics’ customers are natural candidates for Botox injections that Allergan facilitates.
The acquisition, though, is just a microcosm of a bigger trend that’s still picking up steam. That trend is, as the industry’s capabilities to restore youth, slim waists, whiten teeth, improve skin, and nip and tuck here and there improve with science, demand for these increasingly effective ‘tweaks’ is soaring. Names like the aforementioned Allergan, Cynosure, Inc. (NASDAQ:CYNO), Zeltiq Aesthetics and Align Technology, Inc. (NASDAQ:ALGN) are all driving impressive growth. And, they’re all looking to expand their footprint in front of the rising tide.
Not every name riding this growth wave is going to be a large cap stock or a household name though. There’s a small cap stock called RepliCel Life Sciences (OTCMKTS:REPCF, CVE:RP) that could soon be turning a lot of heads not just of investors, but of potential suitors.
In simplest terms, RepliCel Life Sciences has two key sciences that serve as the foundation for three therapies and one medical device.
The first of the two biological premises is based on the company’s non-bulbar dermal sheath fibroblast platform, and currently includes treatments for chronic tendinosis and skin aging. The second is the company’s dermal sheath cup (DSC) cell platform for the treatment of androgenetic alopecia (pattern baldness).
The three marketable products those two sciences are driving are RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair regeneration. The device is a dermal injector – currently categorized as R
Best High Tech Stocks To Buy Right Now: Energy Focus, Inc.(EFOI)
- [By Peter Graham]
Meanwhile, small cap Energy Focus Inc (NASDAQ: EFOI) calls itself an industry-leading innovator of energy-efficient LED lighting technology that aims to be the trusted leader in LED lighting retrofit. As the creator of the first, and so far, only UL-verified low-flicker LED products on the U.S. market, Energy Focus products provide extensive energy and maintenance savings, and aesthetics, safety, health and sustainability benefits over conventional lighting. Customers include national, state and local U.S. government agencies (thanks to numerous research and development projects for the DOE and DARPA) as well as Fortune 500 companies, the U.S. Navy and many others.
- [By Lisa Levin]
Shares of Energy Focus Inc (NASDAQ: EFOI) were down 40 percent to $7.95 after the company reported weaker-than-expected Q4 results.
Omega Protein Corporation (NYSE: OME) was down, falling around 20 percent to $17.47 after the company reported weaker-than-expected results for its fourth quarter.
Best High Tech Stocks To Buy Right Now: NOW Inc.(DNOW)
- [By Matthew DiLallo, Tyler Crowe, and Jason Hall]
Oil prices haven’t gotten off to the fast start many expected, falling around 6% on average during the first quarter of the year. That slump came despite OPEC’s best efforts since producing nations have achieved fairly good compliance on their planned output cuts. That said, despite the lackluster oil market, we still see some interestingopportunities in the oil market. Three stocks we really like right now are DistributionNOW(NYSE:DNOW),Phillips 66(NYSE:PSX), andConocoPhillips(NYSE:COP), which all should do well in the current oil market.
Best High Tech Stocks To Buy Right Now: HD Supply Holdings, Inc.(HDS)
- [By Lisa Levin]
Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.
- [By Trey Thoelcke]
HD Supply Holdings Inc.s (NASDAQ: HDS) latest quarterly earnings report is expected before Wednesday’s open. The consensus estimates call for a profit of $0.64 in per share and $1.35 billion in revenue. Shares closed trading most recently at $33.02, in a 52-week range of $28.97to $44.73. The consensus price target is $39.00.
- [By WWW.THESTREET.COM]
Next, on Tuesday, Cramer’s eyes will be on HD Supply (HDS) , the little-known construction supplier with 500,000 customers. This is one investors need to know about, Cramer said.